The story of fake impact factor companies and how we detected them.
Journal Title: Electronic Physician - Year 2015, Vol 7, Issue 2
Abstract
Beginning about three years ago, the world of academic publishing has become infected by fake impact factors and misleading metrics that are launched by bogus companies. The misleading metrics and fake impact factors have damaged the prestige and reliability of scientific research and scholarly journals. This article presents the in-depth story of some of the main bogus impact factors, how they approached the academic world, and how the author identified them. Some names that they use are Universal Impact Factor (UIF), Global Impact Factor (GIF), and Citefactor, and there even is a fake Thomson Reuters Company.
Authors and Affiliations
Mehrdad Jalalian
Keywords
Related Articles
- EP ID EP138663
- DOI 10.14661/2015.1069-1072
- Views 118
- Downloads 0
Meanings of Health for Iranian Diabetic Patients: A qualitative study
INTRODUCTION: Health is an exclusive and subjective phenomenon, and one of the most important situations with regard to perception of health, arises when patients suffer from a chronic disease. This study was conducted w...
Epidemiological aspect of scorpion sting in Bandar Abbas, Iran, during 2009–2011
INTRODUCTION: People in tropical and semi-tropical areas are in danger of scorpion sting, and this can be a serious problem for them. Mortality due to scorpion sting in the tropical and semi-tropical areas of Iran is abo...
Assessment of life skills of medical students in Mashhad, Iran, in 2015
BACKGROUND: Developing social skills and mental health is a crucial part of the psychosocial health status of medical students. OBJECTIVE: The aim of this study was to assess the life skills of medical students in Mashh...
Effects of a single rectal dose of Misoprostol prior to abdominal hysterectomy in women with symptomatic leiomyoma: a randomized double blind clinical trial.
Fibroma, the most common benign pelvic tumor in women, affects 25 to 30% of women of reproductive age. Primary treatment for patients with symptomatic or large fibroma is surgery.
Coping response following a diagnosis of breast cancer: A systematic review.
Coping with breast cancer is an important health issue that results in adjustments to the disease in survivors. The present systematic review aims to synthesize the evidence about the coping strategies used by women who...